Cercar
01/09/2025
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
Veszelei, I, Godman, B, Aaltonen, K, Selke, GW, Garuoliene, K, Cangini, A, Kurdi, A, Rodrigues, AT, Pontes, C, Torre, C, Lunghi, C, Burton, E, Poplavska, E, Jónsdóttir, F, Petrova, G, Langner, I, Iaru, I, Odnoletkova, I, Slaby, J, Gvozdanovic, K, Saastamoinen, L, Laius, O, Benkö, R, Ziogaite, S, McTaggart, S, Mueller, T, de Pando, T, Tesar, T, Mitkova, Z, Wettermark, B. Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability. BIODRUGS. 2025; 39(5)DOI:10.1007/s40259-025-00732-2. PMID:40779010. IF:6.900(Q1/1D).
12/08/2025
Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023
Brunet-Mas, E, Garcia-Sagué, B, Vela, E, Pontes, C, Melcarne, L, Frisancho, LE, Llovet, LP, Pedregal-Pascual, P, Lario, S, Ramírez-Lázaro, MJ, Villoria, A, Calvet, X. Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023. Journal of Clinical Medicine. 2025; 14(16)DOI:10.3390/jcm14165711. PMID:40869536. IF:2.900(Q1/2D).
01/04/2025
Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study
Arbat, A, Canals, I, Coimbra, J, Molina-Perelló, P, Llorens, M, Torres, R, Perello, J, Moral-Blanch, M, Antonijoan, RM, Calaf, J. Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study. International Journal of Fertility & Sterility. 2025; 19(2)DOI:10.22074/ijfs.2024.2013704.1554. PMID:40200776. IF:0.471(Q4/10D).
25/03/2025
Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis
Lopez-Rey, BG, Carot-Sans, G, Ouchi, D, Torres, F, Pontes, C. Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1548997. PMID:40201693. IF:4.800(Q1/2D).
13/12/2024
A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience
Filippi-Arriaga, F, Molina, P, Delgado-Espinoza, CE, Antonijoan, R. A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience. MEDICINA CLINICA. 2024; 163(11)DOI:10.1016/j.medcli.2024.06.001. PMID:39043476. IF:2.100(Q2/3D).
18/11/2024
A 25-Year Retrospective of Health IT Infrastructure Building: The Example of the Catalonia Region
Piera-Jiménez, J, Carot-Sans, G, Ramiro-Pareta, M, Nogueras, MM, Folguera-Ródenas, J, Ródenas, P, Jiménez-Rueda, A, Navarro, TD, Palacios, JAM, Fajardo, JC, Campillo, JU, Vela, E, Monterde, D, Valero-Bover, D, Bonet, T, Tarrasó-Urios, G, Cantenys-Saba, R, Fabregat-Fabregat, P, Oliveros, BG, Berdún, J, Michelena, X, Cano, I, González-Colom, R, Roca, J, Solans, O, Pontes, C, Pérez-Sust, P. A 25-Year Retrospective of Health IT Infrastructure Building: The Example of the Catalonia Region. JOURNAL OF MEDICAL INTERNET RESEARCH. 2024; 26DOI:10.2196/58933. PMID:39556831. IF:6.000(Q1/1D).